NATCOPHARM.NSNATCOPHARM.NSNSE
Loading
R&D Expenses Over TimeStable
Percentile Rank53
3Y CAGR+5.3%
5Y CAGR-6.1%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+5.3%/yr
vs -17.0%/yr prior
5Y CAGR
-6.1%/yr
Recent acceleration
Acceleration
+22.2pp
Accelerating
Percentile
P53
Within normal range
vs 5Y Ago
0.7x
Contraction
PeriodValueYoY Change
TTM$1.04B0.0%
2025$1.04B-14.1%
2024$1.21B+35.8%
2023$892.00M-47.0%
2022$1.68B+18.0%
2021$1.43B-7.6%
2020$1.54B-17.8%
2019$1.88B+46.7%
2018$1.28B+37.5%
2017$930.00M-